Clinical Trial

Intradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated January 22, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Chronic kidney disease and renal replacement treatments (hemodialysis, peritoneal dialysis, kidney transplant) produce various alterations at the level of muscle, bones, fat content and the heart; can alter physical capabilities such as muscle strength, resistance to climb a step repeatedly intensely, and the ability to move the joints freely, in addition to producing an increase or decrease in weight and alterations in its distribution (for example, decreasing muscle and increase fat). The above, added to the particular factors of hemodialysis such as the reduction in daily time to exercise due to the sessions, or the fatigue after it, can together generate greater repercussions on functional capacity and thus increase the risk of suffering from cardiovascular problems. and accelerate the evolution of the disease. Therefore, this study aims to determine the effect of a 12-week supervised physical exercise program during hemodialysis on strength and ability to move, the amount of fat and muscle in the body, as well as bone wear. ; and compare these results with a group of patients who do not perform supervised exercise. In addition, it will be determined how exercise can act in the long term, preventing the risk of hospitalization and death due to cardiovascular causes. The above is useful in order to establish recommendations and protocols that help us increase the quality of life and survival of the person.
Trial Details
NCT Number NCT06788054
Lead Sponsor Universidad de Guanajuato
Conditions Hemodialysis, Kidney Disease, Chronic, Physical Activity, Physical Deconditioning, Physical Function, Survival, Body Composition
Enrollment 50 participants
Start Date 2025-01-20
Primary Completion 2025-08-30 (estimated)
Study Completion 2026-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-01-22